대한영상의학회지 (Journal of the Korean Society of Radiology)

  • 제82권5호
  • /
  • Pages.1066-1082
  • /
  • 2021
  • /
  • 1738-2637(pISSN)
  • /
  • 2288-2928(eISSN)
대한영상의학회 (The Korean Society of Radiology)
권호 표지
DOI QR코드

DOI QR Code

난소-자궁부속기 종괴: 다중기법 MR 영상의 임상 적용과 O-RADS MRI

Adnexal Masses: Clinical Application of Multiparametric MR Imaging & O-RADS MRI

  • 엄소영 (가톨릭대학교 의과대학 서울성모병원 영상의학과) ;
  • 나성은 (가톨릭대학교 의과대학 서울성모병원 영상의학과)
  • So Young Eom (Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Sung Eun Rha (Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • 투고 : 2021.06.14
  • 심사 : 2021.07.26
  • 발행 : 2021.09.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

초음파에서 우연히 접하는 자궁부속기 병변은 양성 병변이 더 흔하지만, 일부는 악성도가 애매한 병변으로 간주되어 추가적인 평가를 위해 다중매개변수 MRI가 필요하다. 고식적 MRI를 통해 해부학적 모양을 살피고, 지방, 출혈, 섬유성 조직, 고형성 조직 등 병변의 구성성분을 파악하여 많은 양성 종괴들을 정확하게 진단할 수 있다. 또한 추가적인 확산강조영상과 역동적 조영증강 기법의 관류영상으로 양성과 악성의 감별 진단 정확도를 높일 수 있다. 최근 자궁부속기 종괴의 악성 위험도를 평가하고, 각 위험도 군에 대한 적절한 조치를 권고하는데 있어 표준화된 의사소통이 가능하도록 하기 위해 난소-자궁부속기 MRI 보고 및 자료시스템(ovarian-adnexal reporting and data system MRI; 이하 O-RADS MRI)이 발표되었다. 본 종설에서는 자궁부속기 종괴의 악성도 예측 및 감별 진단을 위한 다중매개변수 MRI의 임상 적용과 O-RADS MRI에 대하여 기술하고자 한다.

Incidental adnexal masses considered indeterminate for malignancy are commonly observed on ultrasonography. Multiparametric MRI is the imaging modality of choice for the evaluation of sonographically indeterminate adnexal masses. Conventional MRI enables a confident pathologic diagnosis of various benign lesions due to accurate tissue characterization of fat, blood, fibrous tissue, and solid components. Additionally, functional imaging sequences, including perfusion- and diffusion-weighted imaging, improve the diagnostic efficacy of conventional MRI in differentiating benign from malignant adnexal masses. The ovarian-adnexal reporting and data system (O-RADS) MRI was recently designed to provide consistent interpretations in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. In this review, we describe the clinical application of multiparametric MRI for the evaluation of adnexal masses and introduce the O-RADS MRI risk stratification system.

키워드

참고문헌

  1. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL, et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 2005;193:1630-1639 https://doi.org/10.1016/j.ajog.2005.05.005
  2. Greenlee RT, Kessel B, Williams CR, Riley TL, Ragard LR, Hartge P, et al. Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial. Am J Obstet Gynecol 2010;202:373.e1-e9 https://doi.org/10.1016/j.ajog.2009.11.029
  3. Sharma A, Apostolidou S, Burnell M, Campbell S, Habib M, Gentry-Maharaj A, et al. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol 2012;40:338-344 https://doi.org/10.1002/uog.12270
  4. Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 2016;387:945-956 https://doi.org/10.1016/S0140-6736(15)01224-6
  5. Meys EM, Kaijser J, Kruitwagen RF, Slangen BF, Van Calster B, Aertgeerts B, et al. Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 2016;58:17-29 https://doi.org/10.1016/j.ejca.2016.01.007
  6. Froyman W, Landolfo C, De Cock B, Wynants L, Sladkevicius P, Testa AC, et al. Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol 2019;20:448-458 https://doi.org/10.1016/S1470-2045(18)30837-4
  7. Van Calster B, Timmerman D, Valentin L, McIndoe A, Ghaem-Maghami S, Testa AC, et al. Triaging women with ovarian masses for surgery: observational diagnostic study to compare RCOG guidelines with an International Ovarian Tumour Analysis (IOTA) group protocol. BJOG 2012;119:662-671 https://doi.org/10.1111/j.1471-0528.2012.03297.x
  8. Meys EMJ, Jeelof LS, Achten NMJ, Slangen BFM, Lambrechts S, Kruitwagen RFPM, et al. Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods. Ultrasound Obstet Gynecol 2017;49:784-792 https://doi.org/10.1002/uog.17225
  9. Sadowski EA, Paroder V, Patel-Lippmann K, Robbins JB, Barroilhet L, Maddox E, et al. Indeterminate adnexal cysts at US: prevalence and characteristics of ovarian cancer. Radiology 2018;287:1041-1049 https://doi.org/10.1148/radiol.2018172271
  10. Basha MAA, Refaat R, Ibrahim SA, Madkour NM, Awad AM, Mohamed EM, et al. Gynecology imaging reporting and data system (GI-RADS): diagnostic performance and inter-reviewer agreement. Eur Radiol 2019;29:5981-5990 https://doi.org/10.1007/s00330-019-06181-0
  11. Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A, Guerra A, Fournier LS, Stojanovic S, et al. Ovarian-adnexal reporting data system magnetic resonance imaging (O-RADS MRI) score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 2020;3:e1919896
  12. Baser E, Erkilinc S, Esin S, Togrul C, Biberoglu E, Karaca MZ, et al. Adnexal masses encountered during cesarean delivery. Int J Gynaecol Obstet 2013;123:124-126 https://doi.org/10.1016/j.ijgo.2013.06.015
  13. Hermans AJ, Kluivers KB, Janssen LM, Siebers AG, Wijnen MHWA, Bulten J, et al. Adnexal masses in children, adolescents and women of reproductive age in the Netherlands: a nationwide population-based cohort study. Gynecol Oncol 2016;143:93-97 https://doi.org/10.1016/j.ygyno.2016.07.096
  14. van Nagell JR Jr, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald JM, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007;109:1887-1896 https://doi.org/10.1002/cncr.22594
  15. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al. Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011;305:2295-2303 https://doi.org/10.1001/jama.2011.766
  16. McEvoy SH, Nougaret S, Abu-Rustum NR, Vargas HA, Sadowski EA, Menias CO, et al. Fertility-sparing for young patients with gynecologic cancer: how MRI can guide patient selection prior to conservative management. Abdom Radiol (NY) 2017;42:2488-2512 https://doi.org/10.1007/s00261-017-1179-3
  17. Rockall AG, Qureshi M, Papadopoulou I, Saso S, Butterfield N, Thomassin-Naggara I, et al. Role of imaging in fertility-sparing treatment of gynecologic malignancies. Radiographics 2016;36:2214-2233 https://doi.org/10.1148/rg.2016150254
  18. Hricak H, Chen M, Coakley FV, Kinkel K, Yu KK, Sica G, et al. Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. Radiology 2000;214:39-46 https://doi.org/10.1148/radiology.214.1.r00ja3939
  19. Kinkel K, Lu Y, Mehdizade A, Pelte MF, Hricak H. Indeterminate ovarian mass at US: incremental value of second imaging test for characterization--meta-analysis and Bayesian analysis. Radiology 2005;236:85-94 https://doi.org/10.1148/radiol.2361041618
  20. Anthoulakis C, Nikoloudis N. Pelvic MRI as the "gold standard" in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 2014;132:661-668 https://doi.org/10.1016/j.ygyno.2013.10.022
  21. Pereira PN, Sarian LO, Yoshida A, Araujo KG, Silva ACB, de Oliveira Barros RH, et al. Improving the performance of IOTA simple rules: sonographic assessment of adnexal masses with resource-effective use of a magnetic resonance scoring (ADNEX MR scoring system). Abdom Radiol (NY) 2020;45:3218-3229 https://doi.org/10.1007/s00261-019-02207-9
  22. Thomassin-Naggara I, Darai E, Cuenod CA, Rouzier R, Callard P, Bazot M. Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 2008;28:111-120 https://doi.org/10.1002/jmri.21377
  23. Thomassin-Naggara I, Darai E, Cuenod CA, Fournier L, Toussaint I, Marsault C, et al. Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 2009;19:1544-1552 https://doi.org/10.1007/s00330-009-1299-4
  24. Thomassin-Naggara I, Toussaint I, Perrot N, Rouzier R, Cuenod CA, Bazot M, et al. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 2011;258:793-803 https://doi.org/10.1148/radiol.10100751
  25. Bernardin L, Dilks P, Liyanage S, Miquel ME, Sahdev A, Rockall A. Effectiveness of semi-quantitative multiphase dynamic contrast-enhanced MRI as a predictor of malignancy in complex adnexal masses: radiological and pathological correlation. Eur Radiol 2012;22:880-890 https://doi.org/10.1007/s00330-011-2331-z
  26. Thomassin-Naggara I, Aubert E, Rockall A, Jalaguier-Coudray A, Rouzier R, Darai E, et al. Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 2013;267:432-443 https://doi.org/10.1148/radiol.13121161
  27. Sadowski EA, Maturen KE, Rockall A, Reinhold C, Addley H, Jha P, et al. Ovary: MRI characterisation and ORADS MRI. Br J Radiol 2021;94:20210157
  28. Masch WR, Daye D, Lee SI. MR imaging for incidental adnexal mass characterization. Magn Reson Imaging Clin N Am 2017;25:521-543 https://doi.org/10.1016/j.mric.2017.03.001
  29. Ha HK, Lim YT, Kim HS, Suh TS, Song HH, Kim SJ. Diagnosis of pelvic endometriosis: fat-suppressed T1-weighted vs conventional MR images. AJR Am J Roentgenol 1994;163:127-131 https://doi.org/10.2214/ajr.163.1.8010198
  30. Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000;16:500-505 https://doi.org/10.1046/j.1469-0705.2000.00287.x
  31. Mohaghegh P, Rockall AG. Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics 2012;32:1751-1773 https://doi.org/10.1148/rg.326125520
  32. Wu TT, Coakley FV, Qayyum A, Yeh BM, Joe BN, Chen LM. Magnetic resonance imaging of ovarian cancer arising in endometriomas. J Comput Assist Tomogr 2004;28:836-838 https://doi.org/10.1097/00004728-200411000-00018
  33. Imaoka I, Wada A, Kaji Y, Hayashi T, Hayashi M, Matsuo M, et al. Developing an MR imaging strategy for diagnosis of ovarian masses. Radiographics 2006;26:1431-1448 https://doi.org/10.1148/rg.265045206
  34. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45:169-184 https://doi.org/10.1016/S0720-048X(02)00303-0
  35. Thoeny HC, Forstner R, De Keyzer F. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012;263:326-342 https://doi.org/10.1148/radiol.12110446
  36. Fujii S, Kakite S, Nishihara K, Kanasaki Y, Harada T, Kigawa J, et al. Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 2008;28:1149-1156 https://doi.org/10.1002/jmri.21575
  37. Davarpanah AH, Kambadakone A, Holalkere NS, Guimaraes AR, Hahn PF, Lee SI. Diffusion MRI of uterine and ovarian masses: identifying the benign lesions. Abdom Radiol (NY) 2016;41:2466-2475 https://doi.org/10.1007/s00261-016-0909-2
  38. Li W, Chu C, Cui Y, Zhang P, Zhu M. Diffusion-weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 2012;37:897-903 https://doi.org/10.1007/s00261-011-9814-x
  39. Duarte AL, Dias JL, Cunha TM. Pitfalls of diffusion-weighted imaging of the female pelvis. Radiol Bras 2018;51:37-44 https://doi.org/10.1590/0100-3984.2016.0208
  40. Busard MP, Mijatovic V, van Kuijk C, Pieters-van den Bos IC, Hompes PG, van Waesberghe JH. Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging. J Magn Reson Imaging 2010;31:1117-1123 https://doi.org/10.1002/jmri.22139
  41. Siegelman ES, Oliver ER. MR imaging of endometriosis: ten imaging pearls. Radiographics 2012;32:1675-1691 https://doi.org/10.1148/rg.326125518
  42. Oh JW, Rha SE, Oh SN, Park MY, Byun JY, Lee A. Diffusion-weighted MRI of epithelial ovarian cancers: correlation of apparent diffusion coefficient values with histologic grade and surgical stage. Eur J Radiol 2015;84:590-595 https://doi.org/10.1016/j.ejrad.2015.01.005
  43. Michielsen K, Vergote I, Op de Beeck K, Amant F, Leunen K, Moerman P, et al. Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol 2014;24:889-901 https://doi.org/10.1007/s00330-013-3083-8
  44. Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer 2017;83:88-98 https://doi.org/10.1016/j.ejca.2017.06.010
  45. Rizzo S, De Piano F, Buscarino V, Pagan E, Bagnardi V, Zanagnolo V, et al. Pre-operative evaluation of epithelial ovarian cancer patients: role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study. Eur J Radiol 2020;123:108786
  46. Jahng GH, Li KL, Ostergaard L, Calamante F. Perfusion magnetic resonance imaging: a comprehensive update on principles and techniques. Korean J Radiol 2014;15:554-577 https://doi.org/10.3348/kjr.2014.15.5.554
  47. Thomassin-Naggara I, Balvay D, Aubert E, Darai E, Rouzier R, Cuenod CA, et al. Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 2012;22:738-745 https://doi.org/10.1007/s00330-011-2329-6
  48. Li HM, Feng F, Qiang JW, Zhang GF, Zhao SH, Ma FH, et al. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors. Abdom Radiol (NY) 2018;43:3132-3141 https://doi.org/10.1007/s00261-018-1569-1
  49. Carter JS, Koopmeiners JS, Kuehn-Hajder JE, Metzger GJ, Lakkadi N, Downs LS Jr, et al. Quantitative multi-parametric MRI of ovarian cancer. J Magn Reson Imaging 2013;38:1501-1509 https://doi.org/10.1002/jmri.24119
  50. Ruiz M, Labauge P, Louboutin A, Limot O, Fauconnier A, Huchon C. External validation of the MR imaging scoring system for the management of adnexal masses. Eur J Obstet Gynecol Reprod Biol 2016;205:115-119 https://doi.org/10.1016/j.ejogrb.2016.07.493
  51. Sasaguri K, Yamaguchi K, Nakazono T, Mizuguchi M, Aishima S, Yokoyama M, et al. External validation of ADNEX MR SCORING system: a single-centre retrospective study. Clin Radiol 2019;74:131-139 https://doi.org/10.1016/j.crad.2018.10.014
  52. Basha MAA, Abdelrahman HM, Metwally MI, Alayouty NA, Mohey N, Zaitoun MMA, et al. Validity and reproducibility of the ADNEX MR scoring system in the diagnosis of sonographically indeterminate adnexal masses. J Magn Reson Imaging 2021;53:292-304 https://doi.org/10.1002/jmri.27285
  53. American College of Radiology. American College of Radiology Committee on O-RADS. O-RADS MR Risk Stratification System Table 2020 Available at. https://www.acr.org/-/media/ACR/Files/RADS/O-RADS/ORADS-MR-Risk-Stratification-System-Table-September-2020.pdf. Published 2020. Assessed Jun 12, 2021